EPSRC | GenomeWeb

EPSRC

NEW YORK (GenomeWeb) – The UK government has awarded £3.9 million ($6.6 million) to fund four new research fellowship projects that will that apply engineering techniques to synthetic biology research, the Engineering and Physical Sciences Research Council said on Friday.

NEW YORK (GenomeWeb News) – The UK and China will jointly provide nearly $400,000 to fund several new research activities involving scientists from both countries working collaboratively on synthetic biology projects.

NEW YORK (GenomeWeb News) – The UK is investing £10 million ($15.1 million) to create a new center to drive the translation of synthetic biology research into industrial applications.

NEW YORK (GenomeWeb News) – The Wellcome Trust and the Engineering and Physical Sciences Research Council today announced they are providing £30 million ($47.5 million) in funding for biomedical engineering solutions to address unmet healthcare issues.

NEW YORK (GenomeWeb News) – The UK government plans to provide a boost to the nation's synthetic biology sector under a new initiative that will provide nearly £6.5 million ($10.2 million) in research funding.

NEW YORK (GenomeWeb News) – The UK's Engineering and Physical Sciences Research Council today announced a £5 million ($7.9 million) five-year grant to a consortium of universities to develop a Web-based synthetic biology platform.

A report on public and stakeholder opinion finds citizens excited and worried about synthetic biology but wanting the field to progress with appropriate safeguards and oversight.

A study by the UK's Advanced Institute of Management Research claims that many companies find it increasingly difficult to partner with universities, despite recent efforts by the government to promote such collaboration. Study co-author Ammon Salter discussed the findings with BTW this week.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.